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Background and aim: There are few studies evaluating physical activity (PA) in patients
with chronic obstructive pulmonary disease (COPD) on long-term oxygen therapy (LTOT).
Aim: To assess PA in hypoxemic COPD patients on LTOT.
Methods: In this cross-sectional study, we compared lung function, arterial blood gases,
respiratory and peripheral muscle strength, 6-min walking distance (6MWD), daily energy
expenditure and steps, and health-related quality of life (HRQL) in COPD patients on LTOT
(LTOT group) versus two groups of control patients not needing LTOT: with (HYPOX) and
without (COPD) exercise-induced desaturations.
Results: Groups did not differ as regards demographics, anthropometrics, peripheral or
respiratory muscle strength. Compared to the other groups, LTOT patients had more severe
airway obstruction and lung hyperinflation, greater number and severity of comorbidities,
shorter 6MWD, as well as lower mean SpO2 during 6MWD and worse quality of life.
LTOT patients had a lower daily energy expenditure, shorter time spent > 3.0 METs and
longer sedentary time compared to the COPD group, and less daily steps compared to the other
groups. No significant difference in any parameter of PA was found between COPD and
HYPOX. In LTOT patients, daily steps showed a strong correlation with 6MWD, and
a moderate correlation with airway obstruction, level of oxygenation, comorbidities and quality
of life but not with peripheral and respiratory muscle strength. In COPD and HYPOX patients,
daily steps were strongly correlated with 6MWD and level of oxygenation as assessed by PaO2
/FiO2. There was no significant correlation between mean SpO2 and 6MWD in any group.
Conclusion: COPD patients on LTOT perform less physical activity than patients not
needing LTOT, both with and without exercise-induced desaturations. Patients with exercise-
induced desaturations do not perform less physical activity than those without.
Keywords: exercise, rehabilitation, activity daily living, COPD
Introduction
Physical activity (PA), defined as any body movement produced by skeletal muscles
resulting in energy expenditure, is a complex behavior characterized by type,
intensity, duration, pattern and perceived of symptoms, and including (but not
limited to) exercise, leisure-time, and domestic and occupational activities.1,2 It
has been calculated that elimination of physical inactivity could prevent between
6% and 10% of the major non-communicable diseases, and increase life expec-
tancy. Higher levels of PA increase healthy and chronic disease-free years and there
is a dose–response association between PA and all-cause and cardiovascular disease
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mortality risk, with protective effects at lower-than-
commonly-recommended intensity levels of walking and
sport/exercise, but not with domestic PA.3–7 Furthermore,
each additional hour of light-intensity PA is associated
with important benefits even among individuals not meet-
ing the PA amount recommended by current PA
guidelines.5
Monitoring daily steps count and activity time is the
most valid measurement of PA and can help patients
achieve an effective daily level of PA.2 Despite recent
great advances in pedometers as a tool to estimate daily
steps, with miniaturized accelerometer apps now available
for use on smartphones, these technologies are still not
used by patients as much as they probably should be.8,9
However according to the above definition of PA,2 direct
measure of daily energy expenditure may be a more appro-
priate mode for assessing PA.
Daily PA of patients with chronic obstructive pulmon-
ary disease (COPD) in the early phases of disease is lower
than that of healthy age-matched controls and it declines
still further over time, with important clinical
consequences.10 In patients with COPD, exercise training
programs improve symptoms, exercise capacity and
health-related quality of life (HRQL), and guidelines for
the management of COPD recommend exercise training
for the vast majority of patients.11,13 However, the
observed benefits do not always translate into enhanced
PA levels.14
Chronic hypoxemia in COPD is a limiting factor asso-
ciated with disease progression that significantly reduces
PA and requires long-term oxygen therapy (LTOT).13–15
Although correction of hypoxemia results in physiological
improvements, LTOT may be related to social isolation
and inactivity due to clinical, physiological and organiza-
tional problems. Despite reports that pulmonary rehabilita-
tion can improve exercise capacity also in these patients,16
there are few studies evaluating PA in COPD patients on
LTOT.17–20 Furthermore, to the best of our knowledge,
there is no information on the influence of exercise-
induced desaturation on PA or on the burden of oxygen-
delivery devices.
We hypothesized that COPD patients on LTOT per-
form less PA than patients not needing LTOT with or
without exercise-induced desaturations. Based on this
hypothesis, the aim of this cross-sectional study was to
compare, by means of assessment of daily steps and
energy expenditure, the PA profile of 3 groups of patients:
hypoxemic COPD patients on LTOT versus two control




The study was performed in 2019 on prospectively recorded
data of patients with COPD consecutively admitted for
pulmonary rehabilitation as out-patients between
June 2015 and December 2018 to Istituti Clinici
Scientifici (ICS) Maugeri, Institute of Lumezzane,
a referral centre for pulmonary rehabilitation and care of
chronic patients including prescription of LTOT and home
non-invasive ventilation. The protocol involving the analy-
sis of these data was approved by the Ethical Committee of
the ICS Maugeri, Pavia, Italy (CEC 2287–26 March 19).
All patients admitted to the center give their written
informed consent for the scientific use of their clinical
data and the study complied with the Declaration of
Helsinki.
Inclusion criteria were: a) age range: 40–85 years; b)
both genders; c) diagnosis of COPD, defined as post-
bronchodilator forced expiratory volume in 1 s (FEV1)
/forced vital capacity (FVC) <0.7,11 d) clinical stability
(pH range: 7.38–7.42, without any change in medications
in the previous 7 days).
Exclusion criteria were: a) previous rehabilitation pro-
gram within the past 6 months; b) orthopaedic or neuro-
logical diseases known to be associated with decreased
PA; c) cognitive or psychiatric disorders.
Patients were divided into 3 groups.
Study Patients
LTOT Group: Patients on LTOT, commencement of LTOT
had to be at least 3 months prior, for up to 24 hrs/day
according to leading guidelines;15 In Italy, LTOT is usually
delivered through nasal prongs as liquid oxygen from a base
unit (stationary system) during rest and by means of portable
cylinders, either carried by the patient (stroller) or trans-
ported by means of a trolley, during daily activities.
Controls
Two control groups were assessed.
HYPOX Group
COPD patients not needing LTOT with exercise-induced
desaturation during the 6-min walking distance (6MWD)
test.
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COPD Group
COPD patients not needing LTOT but without any exer-
cise-induced desaturation during the 6MWD test.
Measurements
The following data were recorded at admission:
● Demographics (age, gender), anthropometrics (body
mass index: BMI,21 and reported number and diagno-
sis of comorbidities, according to the Cumulative
Illness Rating Scale (CIRS) including the
Comorbidity Index (CI) and the Severity Index (SI).22
● Only for the LTOT group: reported date of LTOT start,
mode of delivery (stroller or trolley) and average
oxygen flow rate at rest and during daily activities.
The following assessments were performed:
● Dynamic and static lung volumes were assessed
according to the American Thoracic Society (ATS)
guidelines23 by means of a body plethysmograph or
a water-sealed spirometer. The predicted values
according to Quanjer were used.24
● Arterial blood gases were assessed by means of an
automated analyzer on samples from the radial artery
with the patient breathing air or oxygen in sitting
position for at least 1 hr. Inspiratory oxygen fraction
(FiO2) was calculated from the oxygen flow accord-
ing to the formula FiO2 = 20% + (O2 L/min × 4).
Patients on LTOT were assessed at their usual pre-
scribed FiO2.
● Exercise tolerance was assessed by means of the
6MWD.25 At the beginning and end of walking,
subjective sensations of dyspnea and leg fatigue
were assessed by means of a modified Borg scale.26
Exercise-induced desaturation was defined as a 4%
drop in pulse oximetry oxygen saturation (SpO2) to
<90% during the test or mean SpO2 <88% during the
test.25 In LTOT patients, the test was performed with
the oxygen flow and device (stroller or trolley) used
by each patient during his/her daily activities.
● Respiratory muscle strength was evaluated as max-
imal inspiratory (MIP) and expiratory (MEP) pres-
sures. An electronic manometer (Precision Medical,
Northampton, PA, USA) was used according to inter-
national recommendations.27
● Quadriceps and biceps muscle strength were assessed
by means of a dynamometer (Chatillon® X-3328
Series, Ametek Inc., Florida, USA) according to
Andrews et al.28 Patients seated on a chair were
asked to extend their knee, with the dynamometer
placed over the ankle. The final measure was the max-
imal voluntary contraction (MVC) expressed in kg.
● Biceps muscle strength was assessed using
a dynamometer (Chatillon® X-3328) according to
Andrews et al.28 Patients seated on a chair with the
elbow flexed at 90 degrees and forearm supinated
were asked to flex their elbow, with the dynamometer
placed just proximal to the ulnar styloid. The final
measure was the maximal voluntary contraction
(MVC) expressed in kg.
● Level of PA was measured using the SenseWear
Armband 2 (Body Media Inc., Pittsburgh, PA,
USA). This device is worn over the right brachial
triceps muscle and incorporates five sensors: a two-
axis accelerometer (for movement patterns and step-
count), galvanic skin response, skin temperature, near
body temperature sensor and heat flux.29 Patients
wore the Armband for 3 consecutive days, including
one weekend day. Evaluable days were those with at
least 20/24 hrs recording. The following parameters
were assessed: mean daily energy expenditure; mean
daily steps; mean daily time (min) spent performing
moderate PA [any minute with ≥ 3 metabolic equiva-
lent tasks (METs); mean daily time spent in
a sedentary state (<1.5 METs in awake status);
mean daily time spent sleeping and lying down].
● Quality of life was assessed by EQ-5D (EuroQol-
Five Dimensions, Score) and EQ-5D-VAS (EuroQol-
Five Dimensions, VAS scale).30
Statistical Analysis
Descriptive statistics are reported as mean and standard
deviation (SD) for continuous variables and as numbers
(n) and percentage frequency (%) for discrete variables.
The analysis of variance (ANOVA) test was used to com-
pare clinical and PA variables among groups and, if the
test was significant, a post hoc analysis by unpaired t-test
with Bonferroni correction was performed.
The correlations between demographic, anthropo-
metric, clinical, physiological variables and daily steps
were analysed by a Spearman correlation evaluation.
Levels of strength of association were according to
Acock.31 Statistical significance for all statistical tests
was set at p < 0.05. All analyses were carried out using
STATA software package (release 11, StataCorp LP).
Dovepress Paneroni et al
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Results
Out of 372 out-patients admitted in the study period, 273
were diagnosed with COPD, and data were available in 200
patients. The demographic, anthropometric, physiological
and clinical characteristics of patients are shown in Table 1.
Groups did not differ in terms of demographics, anthropo-
metrics, quadriceps and biceps maximal voluntary contrac-
tion (MVC) or respiratory muscle strength. As expected,
compared with the two control groups, patients on LTOT
had more severe airway obstruction and lung hyperinflation,
a greater number and severity of comorbidities and a lower
exercise capacity as assessed by 6MWD, as well as a lower
mean SpO2 during 6MWD and worse HRQL. As compared
with the COPD group, the HYPOX group had lower dynamic
volumes, mean SpO2 during 6MWD and PaO2/FiO2.
The mean time of LTOT use was 59.6 (36.9) months.
During their daily activities, 34 (82.9%) patients on LTOT
used a stroller, whereas only 7 (17.1%) used a trolley. All
patients used nasal prongs. The average oxygen flow was
1.2 (0.75) L/min at rest, whereas during walking it was
3.01 (0.91) L/min. Patients using a stroller showed signif-
icantly higher quadriceps [31.3 (10.2) vs 20.6 (4.5) kg,
respectively; p=0.0105] and respiratory muscle strength
[83.6 (22.1) vs 56.4 (20.9) cmH2O, p=0.005 and 104.0
(31.0) vs 71.1 (36.6) cmH2O, p=0.0162 for MIP and MEP,
respectively] than patients using trolleys. Patients with
a stroller performed longer 6MWD than patients using
a trolley [370.1 (107.7) vs 278.1 (57.9) m, respectively,
p=0.036].
Physical Activity
Table 2 shows the mean parameters of PA as assessed by
the Armband. The LTOT group had a lower energy expen-
diture, shorter time spent at >3.0 METs and longer seden-
tary time than the COPD group. The LTOT group
performed less daily steps compared to both other groups,
whereas there was no significant difference in any para-
meter of PA between COPD and HYPOX (Figure 1).
Only the total energy expenditure was significantly
lower in trolley users as compared to patients using
a portable cylinder [1724 (206) vs 2116 (420) Cal/day
P=0.022, respectively] (Figure 2).
Table 3 shows the correlations between daily steps and
PA parameters. Daily steps showed a strong correlation
only with energy expenditure.
Table 4 shows the correlations between patient char-
acteristics and daily steps. In COPD and HYPOX patients,
daily steps were strongly correlated with 6MWD and level
Table 1 Demographic, Anthropometric, Physiological and Clinical Characteristics of Patients. Mean (SD) or n (%)
All Patients (n=200) COPD (n=96) HYPOX (n=63) LTOT (n=41) P
Male, % 77.0 78.1 74.6 78.0 0.861
Age, years 68.7 (9.1) 69.9 (8.6) 67.9 (11.0) 67.0 (6.4) 0.153
BMI, kg/m2 26.3 (5.4) 26.6 (5.0) 26.3 (6.0) 25.6 (5.4) 0.655
6MWD, m 432.0 (111.5) 457.8 (97.9) 442.3 (113.5) 354.0 (106.2) <0.001 (&=<0.001, #=<0.001)
Mean SpO2 6MWD, % 90.54 (3.82) 93.50 (2.07) 88.47 (2.60) 86.76 (3.15) <0.001 (*=<0.001, &=<0.001, #=0.003)
FEV1, % pred. 61.5 (23.6) 72.3 (21.1) 57.5 (21.5) 42.9 (18.3) <0.001 (*=<0.001, &=<0.001, #=0.002)
FVC, % pred. 87.1 (21.7) 95.0 (20.6) 83.1 (20.4) 75.5 (19.4) <0.001 (*=0.003, &=<0.001)
FEV1/FVC,% 53.3 (16.8) 57.6 (12.4) 52.7 (20.7) 44.0 (15.3) <0.001 (&=<0.001, #=0.033)
RV, % pred. 143.7 (49.1) 133.3 (36.0) 149.3 (49.1) 159.9 (68.0) 0.027 (&=0.034)
CI, score 1.6 (0.3) 1.6 (0.3) 1.6 (0.3) 1.8 (0.3) <0.001 (&=0.002, #=0.001)
SI, score 2.8 (1.6) 2.8 (1.5) 2.5 (1.7) 3.4 (1.4) 0.023 (#=0.020)
PaO2/FiO2 340 (54) 366 (44) 337 (47) 284 (42) <0.001 (*=<0.001, &=<0.001, #=<0.001)
PaCO2, mmHg 37.94 (4.78) 36.9 (4.1) 37.6 (4.2) 40.7 (5.8) <0.001 (&=<0.001, #=0.003)
MVC quadriceps, kg 30.4 (10.6) 29.8 (10.2) 31.8 (11.6) 29.4 (10.3) 0.422
MVC biceps, kg 22.0 (7.4) 22.8 (7.7) 22.4 (7.3) 19.8 (6.2) 0.079
MIP, cmH2O 75.0 (23.3) 72.4 (25.0) 76.2 (19.8) 79.0 (24.0) 0.286
MEP, cmH2O 101.3 (34.6) 102.1 (35.7) 101.9 (32.9) 98.4 (33.6) 0.839
EQ-5D, score 0.68 (0.34) 0.72 (0.31) 0.71 (0.30) 0.54 (0.47) 0.035 (&=0.037)
EQ-5D-VAS 64.0 (19.7) 66.3 (19.5) 62.2 (21.7) 61.0 (15.0) 0.333
Notes: P=ANOVA test. In brackets P of post hoc analysis with Bonferroni correction: #= LTOT vs HYPOX; & = LTOT vs COPD; * = COPD vs HYPOX.
Abbreviations: 6MWD, 6-min walk distance; BMI, body mass index; CI, Comorbidity Index; COPD, chronic obstructive pulmonary disease; EQ-5D, EuroQol five
dimension questionnaire; EQ-5D-VAS, EuroQol five dimension – VAS; FEV1, forced expiratory flow in one second; FVC, forced vital capacity; MEP, maximal expiratory
pressure; MIP, maximal inspiratory pressure; MVC, maximal voluntary contraction; PaCO2, arterial carbon dioxide tension; PaO2, arterial oxygen tension; SI, Severity Index.
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of oxygenation as assessed by PaO2/FiO2, whereas in
patients on LTOT daily steps showed a strong correlation
with 6MWD, and only a moderate correlation with airway
obstruction, level of oxygenation, comorbidities and qual-
ity of life, but not with peripheral or respiratory muscle
strength. There was no significant correlation with mean
SpO2 during the 6MWD test in any group.
Discussion
Our study confirms that COPD patients on LTOT perform
less PA than patients not needing LTOT, whether with or
without exercise-induced desaturations. Two novel find-
ings of our study are that patients with exercise-induced
desaturations (HYPOX group) did not perform less PA
than patients without exercise-induced desaturations
(COPD group), and that patients under LTOT carrying
full-weight oxygen portable cylinders (stroller) walked
a longer distance and showed higher energy expenditure
than patients pulling a small-wheeled cart transporting
a full-weight oxygen cylinder (trolley).
In patients not needing LTOT, daily steps were strongly
correlated with 6MWD and level of oxygenation, whereas
in patients on LTOT daily steps showed a strong correla-
tion with 6MWD, and a moderate correlation with airway
obstruction, level of oxygenation, comorbidities and
HRQL. These findings are similar to those by Garcia-
Aymerich et al17 who found that comorbidities, HRQL,
and LTOT were the only factors independently associated
with a low PA level in severe COPD patients.
An advantage of the current study is that, in contrast to
other studies using questionnaires, we directly assessed
daily PA by means of a multisensory armband including
measurement of daily steps. Questionnaires have some
methodological problems, like recall, which may become
a limitation if not addressed in the development and vali-
dation process.2 Like other devices, the accelerometer we
used has been shown to be valid and reliable for use in
COPD.32 Indeed, these devices seem to give more com-
plete information on PA as defined by Caspersen et al.1 As
a matter of fact, in our study, daily steps showed a good










Total Energy Expenditure, Cal/day 2219 (537) 2264 (592) 2261 (503) 2049 (418) 0.074
Energy expenditure, mean METs 1.3 (0.5) 1.3 (0.3) 1.3 (0.2) 1.2 (0.2) 0.034 (&=0.035)
Time spent lying down, min/day 509.9 (127.8) 528.9 (112.6) 489.5 (150.0) 496.0 (121.1) 0.122
Time spent sleeping, min/day 412.0 (122.8) 422.2 (114.1) 404.4 (139.7) 398.7 (117.5) 0.523
Energy expenditure < 1.5METs,min/day 1107.1 (203.9) 1069.3 (242.8) 1104.9 (149.1) 1199.1 (142.7) 0.003 (&=0.002)
Time spent > 3.0 METs, min/day 82.6 (155.0) 112.0 (209.8) 66.4 (72.1) 38.6 (50.6) 0.025 (&=0.035)
Daily steps, steps/day 5033 (3304) 5740 (3486) 5394 (3150) 2822 (1908) <0.001 (&=<0.001, #=0.001)
Sedentary time, min/day 689.2 (220.4) 642.7 (254.8) 692.3 (160.8) 794.3 (168.3) 0.001 (&=0.001)
Notes: P=ANOVA test. In brackets P of post hoc analysis with Bonferroni correction: & = LTOT vs.COPD, # = LTOT vs HYPOX.
Figure 1 Daily steps. ANOVA test p<0.001. Difference between groups: *LTOT vs
HYPOX: p<0.001; °LTOT vs COPD: p<0.001.
Figure 2 Comparison of total energy expenditure (Cal/day) between trolley and
portable cylinder users in the LTOT group. Difference between groups: *p=0.022.
Portable Cyl= portable cylinder. Cal/day=Calories/day.
Dovepress Paneroni et al
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correlation with the energy expenditure assessed with the
same device (Table 3).
Using the same device, a multi-center study conducted
on more than 1000 COPD patients33 reported that age,
BMI, dyspnea severity and airflow obstruction were asso-
ciated with PA measures and hourly patterns. In a recent
smaller study,20 patients on LTOT showed less time walk-
ing, as well as in physical activities, in physical activities
≥ 3 METs, and in physical activities < 1.5 METs, and took
fewer steps compared to control patients not needing
LTOT. Physical inactivity was present in 83% of LTOT
subjects and 60% of control subjects. Oxygen therapy was
significantly associated with severe physical inactivity.
The time using oxygen therapy was the strongest predictor
of the level of PA. In another study,34 HRQL was lower in
patients with COPD and exertional hypoxemia who were
not adherent to LTOT than it was in those who did.
We did not find any difference in PA between patients
with vs without exercise-induced desaturations. Our results
may represent an indirect confirmation of those by Alison
et al35 who showed that supplemental oxygen during exercise
training in patients with COPD with oxygen desaturation
<90% during the 6MWD did not result in greater benefit
than medical air in exercise capacity and HRQL.35 These
results may be explained with the method of recruitment of
patients referred for pulmonary rehabilitation and potentially
with greater exercise capacity due to the exercise training
program performed by the patients of study.35 Whether the
exercise stimulus would have overwhelmed that of oxygen
saturation remains speculative.
One study36 showed that exercise-induced desaturation
was a predictive factor for decline in 6MWD in patients
with COPD. Oxygen therapy improves exercise tolerance in
hypoxemic COPD patients, but whether activity levels are
also enhanced is unclear. A small, randomized trial in which
Table 4 Significant Correlations Between Patient Characteristics and Daily Steps
All Patients COPD HYPOX LTOT
R P R P R P R P
Age, years −0.2853 <0.001 −0.4581 <0.001 −0.3151 0.012
BMI, kg/m2
6MWD, m 0.5798 <0.001 0.5106 <0.001 0.5736 <0.001 0.5418 <0.001
Mean SpO2 during 6MWD, % 0.1692 0.023
FEV1, % pred. 0.3054 <0.001 0.4725 0.002
FVC, % pred. 0.2893 <0.001 0.3173 0.017
FEV1/FVC,% 0.1692 0.023
RV, % pred. −0.1878 0.023 −0.3149 0.040
CI, score 0.1651 0.027 −0.3955 0.015
SI, score −0.3653 0.026
PaO2/FiO2 0.5222 <0.001 0.3700 0.001 0.5453 <0.001 0.4298 0.005
PaCO2, mmHg
MVC quadriceps, Kg 0.3043 <0.001 0.2502 0.014 0.4453 <0.001
MVC biceps, kg 0.2991 <0.001 0.4921 <0.001
MIP, cmH2O 0.1693 0.017 0.2223 0.029 0.3039 0.015
MEP, cmH2O 0.2489 0.001 0.4050 0.001
EQ-5D, score 0.4721 0.007
EQ-5D-VAS 0.2896 0.001
Notes: Color legend: pale yellow = weak correlation (r=|0-0.299|), pale pink = moderate correlation (r=|0.3–0.499|), red = strong correlation (r >|0.5|), grey= no significant
correlation.30
Abbreviations: BMI, Body-Mass Index; CI, Comorbidity Index; EQ-5D, EuroQol five dimension questionnaire; EQ-5D-VAS, EuroQol five dimension – VAS; FEV1, Forced
Expiratory Flow in one second; FVC, Forced Vital Capacity; MIP, Maximal Inspiratory Pressure; MEP, Maximal Expiratory Pressure; MVC, Maximal Voluntary Contraction;
PaCO2, arterial carbon dioxide tension; PaO2, arterial oxygen tension; RV, Residual volume; SI, Severity Index; 6MWD, Six minute walk distance.
Table 3 Correlations Between Daily Steps and Parameters of
Physical Activity
R P
Total Energy Expenditure, Cal/day 0.5889 <0.001
Energy expenditure, mean METs 0.4212 <0.001
Time spent lying down, min/day −0.2298 0.001
Time spent sleeping, min/day −0.1811 0.013
Energy expenditure <1.5 METs, min/day −0.4117 <0.001
Time spent > 3.0 METs, min/day 0.4136 <0.001
Sedentary time, min/day −0.2880 <0.001
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heavier oxygen tanks were replaced with light-weight
ambulatory oxygen therapy failed to detect improvements
in PA over a 6-month period.2,37 We found that patients on
LTOT carrying a portable device (stroller) performed longer
walking distance and showed higher energy expenditure
than those using a trolley to transport their oxygen cylinder.
Our results differ from those of a multicenter cross-over
trial which reported that a full-weight oxygen canister trans-
ported using a small-wheeled cart and pulled by the patients
was more helpful to patients than a full-weight oxygen
canister carried on the patient’s shoulder, enabling them to
walk longer.38 However, in that study no significant differ-
ences were observed in the subgroup of patients walking
longer than 300 m and the mean distance walked by our
LTOT patients was 354 m.
We found a moderate correlation between daily steps
and airway obstruction but not hyperinflation only in
patients under LTOT. Overall, studies show that while
increasing severity of lung function impairment is asso-
ciated with reduced PA in subjects with COPD, the rela-
tionship is relatively weak. Therefore, levels of PA cannot
be accurately predicted from resting lung function
parameters.2,39
Neither peripheral nor respiratory muscle strength dif-
fered among groups, while they moderately correlated with
daily steps only in COPD patients with exercise-induced
desaturation. Quadriceps muscle strength and mass are com-
monly reduced in patients with COPD, and have been found
to be positively correlated with PA in other studies.2,40
Rather interestingly, a moderate correlation was found
between daily steps and HRQL only in patients on LTOT.
This being a cross-sectional study, it is difficult to say
whether patients have a better level of PA because of
a better HRQL, or a better HRQL because of higher PA.
Various assessments of health status have been related to
PA measurements in patients with COPD. Most studies
showed that an impaired health status is weakly to mod-
erately related to a lower PA amount and intensity.
Changes in PA over time parallel trends in health
status.17,41 Since most health status questionnaires have
items addressing PA this could obviously affect these
relationships.2
The only consistent correlation of daily steps in all
groups was found with 6MWD. Our results confirm pre-
vious studies showing that 6MWD, even though moder-
ately associated with PA, is of limited value to reliably
identify physically inactive COPD patients.42,43 This lack
of a strong correlation between exercise performance and
PA is not surprising. Exercise is only a planned, structured,
repetitive and purposeful subset of PA.2 Furthermore, this
finding may also explain that the observed benefits of
exercise training do not consistently translate into
enhanced PA levels.12,14 PA is, in fact, dependent on
many other elements, including biological, behavioral,
genetic, social, environmental, and cultural factors.2
Different patterns of change in activity levels following
pulmonary rehabilitation can be found in patients with
COPD. Focusing on light PA might be a potential strategy
to make patients less sedentary.44 Benefits of a low-
intensity intervention may be limited to patients with
moderate airway obstruction.45 Physical activity can
enhance the benefits of smoking cessation. Former smo-
kers who are physically active may show a similar
improvement in HRQL to that of non-smokers.46
Our results must be interpreted with caution. The
recruited patients were referred to a pulmonary rehabilita-
tion program. This method of recruiting patients might
have resulted in the selection of more healthy patients
with LTOT. It could also indicate that patients with
a potential for improvement in exercise capacity were
selected. Patients on LTOT had used oxygen therapy for
almost 5 years, a relatively long period. This could indi-
cate a potential healthy survivor bias in the study.
Therefore, the result of our study might be valid only for
this subgroup of LTOT patients
Conclusion
COPD patients on LTOT perform less physical activity
than COPD patients not needing LTOT, whether they are
with or without exercise-induced desaturations. Patients
with exercise-induced desaturations do not perform less
physical activity than patients without. The use of
a portable cylinder is associated with better functional
capacity than the use of a trolley. These findings may be
helpful in planning rehabilitation programs and in deter-
mining the practical mode for performing LTOT at least in
patients with the clinical characteristics of our study.
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